Dr. Scott C. Solcher, MD
Nephrology (Kidney) (Nephrology Physician)
- Medicare participating
At a glance
- Medical school
- University of Oklahoma College of Medicine (1991)
- Years since graduation
- 35
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 704
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1991Medical school: University of Oklahoma College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
KS license 04-24393
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Stormont Vail Hospital Topeka, KS
- Lmh Lawrence, KS
- University of Kansas Health System - St Francis Campus Topeka, KS
- Community Hospital, Onaga and St Marys Campus Onaga, KS
- Coffey County Hospital Burlington, KS
Medical groups
- Cotton-O'neil Clinic Revocable Trust (666 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 704
- Services billed
- 3,895
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 1,314 | 12 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 520 | 219 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 290 | 49 |
| Established patient office or other outpatient visit, 20-29 minutes | 241 | 206 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 153 | 75 |
| Insertion of needle into vein for collection of blood sample | 151 | 52 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 121 | 44 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 99 | 84 |
| Home dialysis services per month (20 years or older) | 99 | 18 |
| New patient office or other outpatient visit, 45-59 minutes | 78 | 78 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 34 payments worth $12,974 in total to this clinician.
| Travere Therapeutics, Inc. | $12,921 |
|---|---|
| Novartis Pharmaceuticals Corporation | $34.68 |
| Vantive US Healthcare LLC | $18.23 |
| Consulting Fee | $9,000 |
|---|---|
| Travel and Lodging | $2,373 |
| Food and Beverage | $801 |
| Speaking at a medical education program | $800 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Travere Therapeutics, Inc. Sep 12, 2025 | Consulting Fee Filspari · Kidney Disease | $3,000 |
| Travere Therapeutics, Inc. Sep 19, 2025 | Consulting Fee Filspari · Kidney Disease | $3,000 |
| Travere Therapeutics, Inc. Sep 26, 2025 | Consulting Fee Filspari · Kidney Disease | $3,000 |
| Travere Therapeutics, Inc. Oct 8, 2025 | Speaking at a medical education program Filspari · Kidney Disease | $800 |
| Travere Therapeutics, Inc. Oct 24, 2025 | Travel and Lodging travel to Minneapolis, MN · in-kind | $569 |
| Travere Therapeutics, Inc. Sep 19, 2025 | Travel and Lodging Filspari · Kidney Disease · travel to Springfield, MO · in-kind | $288 |
| Travere Therapeutics, Inc. Sep 3, 2025 | Travel and Lodging Filspari · Kidney Disease · travel to Sandy, UT · in-kind | $263 |
| Travere Therapeutics, Inc. Sep 3, 2025 | Travel and Lodging Filspari · Kidney Disease · travel to Sandy, UT · in-kind | $249 |
| Travere Therapeutics, Inc. Oct 11, 2025 | Travel and Lodging travel to Minneapolis, MN · in-kind | $240 |
| Travere Therapeutics, Inc. Sep 3, 2025 | Travel and Lodging Filspari · Kidney Disease · travel to Sandy, UT · in-kind | $186 |
All 21 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Travere Therapeutics, Inc. Oct 29, 2025 | Travel and Lodging travel to Minneapolis, MN · in-kind | $131 |
| Travere Therapeutics, Inc. Oct 29, 2025 | Travel and Lodging travel to Minneapolis, MN · in-kind | $70.48 |
| Travere Therapeutics, Inc. Oct 24, 2025 | Travel and Lodging travel to Minneapolis, MN · in-kind | $569 |
| Travere Therapeutics, Inc. Oct 11, 2025 | Travel and Lodging travel to Minneapolis, MN · in-kind | $240 |
| Travere Therapeutics, Inc. Oct 8, 2025 | Speaking at a medical education program Filspari · Kidney Disease | $800 |
| Travere Therapeutics, Inc. Oct 2, 2025 | Travel and Lodging Filspari · Kidney Disease · travel to Leawood, KS · in-kind | $29.47 |
| Travere Therapeutics, Inc. Oct 2, 2025 | Travel and Lodging Filspari · Kidney Disease · travel to Leawood, KS · in-kind | $26.88 |
| Travere Therapeutics, Inc. Sep 26, 2025 | Consulting Fee Filspari · Kidney Disease | $3,000 |
| Travere Therapeutics, Inc. Sep 19, 2025 | Consulting Fee Filspari · Kidney Disease | $3,000 |
| Travere Therapeutics, Inc. Sep 19, 2025 | Travel and Lodging Filspari · Kidney Disease · travel to Springfield, MO · in-kind | $288 |
| Travere Therapeutics, Inc. Sep 19, 2025 | Travel and Lodging Filspari · Kidney Disease · travel to Sandy, UT · in-kind | $92.40 |
| Travere Therapeutics, Inc. Sep 19, 2025 | Travel and Lodging Filspari · Kidney Disease · travel to Sandy, UT · in-kind | $59.49 |
| Travere Therapeutics, Inc. Sep 19, 2025 | Travel and Lodging Filspari · Kidney Disease · travel to Sandy, UT · in-kind | $56.00 |
| Travere Therapeutics, Inc. Sep 19, 2025 | Travel and Lodging Filspari · Kidney Disease · travel to Sandy, UT · in-kind | $37.73 |
| Travere Therapeutics, Inc. Sep 19, 2025 | Travel and Lodging Filspari · Kidney Disease · travel to Sandy, UT · in-kind | $37.73 |
| Travere Therapeutics, Inc. Sep 12, 2025 | Consulting Fee Filspari · Kidney Disease | $3,000 |
| Travere Therapeutics, Inc. Sep 3, 2025 | Travel and Lodging Filspari · Kidney Disease · travel to Sandy, UT · in-kind | $263 |
| Travere Therapeutics, Inc. Sep 3, 2025 | Travel and Lodging Filspari · Kidney Disease · travel to Sandy, UT · in-kind | $249 |
| Travere Therapeutics, Inc. Sep 3, 2025 | Travel and Lodging Filspari · Kidney Disease · travel to Sandy, UT · in-kind | $186 |
| Travere Therapeutics, Inc. Sep 3, 2025 | Travel and Lodging Filspari · Kidney Disease · travel to Sandy, UT · in-kind | $18.00 |
| Travere Therapeutics, Inc. Sep 3, 2025 | Travel and Lodging Filspari · Kidney Disease · travel to Sandy, UT · in-kind | $18.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.